Cheng Zhang,Shuqian Jing,Hua Zhang,Xiaofeng Wang,Chenjiang Yao
申请号：
US14911715
公开号：
US10059773B2
申请日:
2014.08.01
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed in the present invention is an antibody specifically binding to GLP-1R and a fusion protein thereof with GLP-1. The fusion proteins can effectively bind to a human GLP-1R receptor and activate a receptor signaling pathway, thus are useful for treating diabetes, excessive weight, obesity and related disorders thereof.
